The NEURESCUE device is the first intelligent catheter for aortic balloon occlusion, an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The catheter-based device is delivered via the femoral artery, temporarily inflating a soft balloon in the descending aorta to redirect blood flow towards the upper body. The objective of this study is to investigate the feasibility of the NEURESCUE device as an adjunct to Advanced Cardiac Life Support (ACLS) in adults with cardiac arrest.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
6
The balloon catheter is delivered via the femoral artery, temporarily inflating a soft balloon in the descending aorta to redirect blood flow towards the upper body.
Long Beach Medical Center
Long Beach, California, United States
Successful balloon inflation within 10 minutes from first vessel puncture
Time frame: Assessed up to 10 min
Change in central blood pressure
Time frame: Assessed up to 1 hour
Total ACLS time at initiation of the investigational procedure
Time frame: Assessed up to 1 hour
Time from first vessel puncture to successful sheath insertion
Time frame: Assessed up to 1 hour
Rate of occlusion success
Time frame: Assessed up to 1 hour
Return of spontaneous circulation (ROSC)
The endpoint is dichotomous (yes/no) for each subject
Time frame: Assessed up to 1 hour
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.